drugset / Trial / NCT00559546

Montelukast as a Controller of Atopic Syndrome

NCT00559546

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to find out if montelukast can be used to treat the various symptoms of allergic syndrome.

Timeline

Start
2007-03
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral